Prerana Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.22 Cr
as on 01-07-2024
- Revenue -19.90%
(FY 2021)
- Profit 265.09%
(FY 2021)
- Ebitda -50.58%
(FY 2021)
- Net Worth 33.74%
(FY 2021)
- Total Assets 3.48%
(FY 2021)
About Prerana Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.22 Cr.
Savita Rangarajan and Venkatesan Rangarajan serve as directors at the Company.
- CIN/LLPIN
U85100MH2014PTC257240
- Company No.
257240
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prerana Medical Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatesan Rangarajan  | Managing Director | 18-Aug-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Savita Rangarajan | Director | 18-Aug-2014 | Current |
Financial Performance of Prerana Medical Sciences.
Prerana Medical Sciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 19.9% decrease. The company also saw a substantial improvement in profitability, with a 265.09% increase in profit. The company's net worth Soared by an impressive increase of 33.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prerana Medical Sciences?
In 2021, Prerana Medical Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prerana Healthcare FoundationActive 10 years 3 monthsSavita Rangarajan and Venkatesan Rangarajan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Apr 2018 | ₹1.60 Cr | Open |
Others Creation Date: 27 Apr 2018 | ₹6.25 M | Open |
How Many Employees Work at Prerana Medical Sciences?
Unlock and access historical data on people associated with Prerana Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prerana Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prerana Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
